These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 8838197)

  • 1. Streptococcal toxic shock syndrome associated with marked gamma delta T cell expansion: case report.
    Arvand M; Schneider T; Jahn HU; Hahn H
    Clin Infect Dis; 1996 Feb; 22(2):362-5. PubMed ID: 8838197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective depletion of V beta-bearing T cells in patients with severe invasive group A streptococcal infections and streptococcal toxic shock syndrome. Ontario Streptococcal Study Project.
    Watanabe-Ohnishi R; Low DE; McGeer A; Stevens DL; Schlievert PM; Newton D; Schwartz B; Kreiswirth B; Kotb M
    J Infect Dis; 1995 Jan; 171(1):74-84. PubMed ID: 7798684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toxic shock syndrome due to group A streptococcal pharyngitis and bacteremia in an adult.
    Vucicevic Z; Bencic IJ; Kruslin B; Degoricija V
    J Microbiol Immunol Infect; 2008 Aug; 41(4):351-4. PubMed ID: 18787744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Streptococcal toxic shock syndrome due to noninvasive pharyngitis.
    Chapnick EK; Gradon JD; Lutwick LI; Kim J; Levi M; Kim MH; Schlievert PM
    Clin Infect Dis; 1992 May; 14(5):1074-7. PubMed ID: 1600009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toxic shock-like syndrome, a complication of strep throat.
    Bradley JS; Schlievert PM; Peterson BM
    Pediatr Infect Dis J; 1991 Oct; 10(10):790. PubMed ID: 1945587
    [No Abstract]   [Full Text] [Related]  

  • 6. Toxic shock syndrome due to group A streptococcal pharyngitis and bacteremia in adults.
    Vucicevic Z; Jajic-Bencic I; Kruslin B; Degoricija V
    J Microbiol Immunol Infect; 2009 Jun; 42(3):276-9. PubMed ID: 19812863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erythrogenic toxins A, B and C: occurrence of the genes and exotoxin formation from clinical Streptococcus pyogenes strains associated with streptococcal toxic shock-like syndrome.
    Reichardt W; Müller-Alouf H; Alouf JE; Köhler W
    FEMS Microbiol Lett; 1992 Dec; 100(1-3):313-22. PubMed ID: 1478466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective stimulation of human T cells with streptococcal erythrogenic toxins A and B.
    Abe J; Forrester J; Nakahara T; Lafferty JA; Kotzin BL; Leung DY
    J Immunol; 1991 Jun; 146(11):3747-50. PubMed ID: 1903412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo and in vitro detection of a superantigenic toxin Vbeta signature in two forms of streptococcal toxic shock syndrome.
    Thomas D; Perpoint T; Dauwalder O; Lina G; Floccard B; Richard JC; Bouvet A; Peyramond D; Allaouchiche B; Chidiac C; Vandenesch F; Etienne J; Ferry T
    Eur J Clin Microbiol Infect Dis; 2009 Jun; 28(6):671-6. PubMed ID: 19020908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T cell activation and cytokine release in streptococcal toxic shock-like syndrome.
    Nadal D; Lauener RP; Braegger CP; Kaufhold A; Simma B; Lütticken R; Seger RA
    J Pediatr; 1993 May; 122(5 Pt 1):727-9. PubMed ID: 8496751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Superantigenic activity produced by group A streptococcal isolates is neutralized by plasma from IVIG-treated streptococcal toxic shock syndrome patients.
    Norrby-Teglund A; Low DE; McGeer A; Kotb M
    Adv Exp Med Biol; 1997; 418():563-6. PubMed ID: 9331714
    [No Abstract]   [Full Text] [Related]  

  • 12. [Properties of extracellular products produced by group A streptococci isolated from patients with streptococcal toxic shock syndrome].
    Suzuki J; Matsubuchi S; Yoshihara E; Kobayashi S; Okamura K; Okuda T; Okazaki M; Furuya N; Uchimura H; Tokunaga T; Shimazaki S
    Kansenshogaku Zasshi; 1997 Dec; 71(12):1187-92. PubMed ID: 9483877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Streptococcal pyrogenic exotoxin A, streptolysin O, exoenzymes, serotype and biotype profiles of Streptococcus pyogenes isolates from patients with toxic shock syndrome and other severe infections.
    Müller-Alouf H; Geoffroy C; Geslin P; Bouvet A; Felten A; Günther E; Ozegowski JH; Alouf JE
    Zentralbl Bakteriol; 1997 Oct; 286(3):421-33. PubMed ID: 9361388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Right in Front of Our Eyes: Evolution of Streptococcal Toxic Shock Syndrome with Ischemic Optic Neuropathy.
    Elhamamsy SM; Al-Qadi MO; Minami T; Neill M
    R I Med J (2013); 2016 Dec; 99(12):47-49. PubMed ID: 27903001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Streptococcal toxic shock syndrome from necrotizing soft-tissue infection of the breast caused by a mucoid type strain.
    Kohayagawa Y; Ishitobi N; Yamamori Y; Wakuri M; Sano C; Tominaga K; Ikebe T
    J Infect Chemother; 2015 Feb; 21(2):144-7. PubMed ID: 25260866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T-cell activation and proliferation in a case of recurrent menstrual toxic shock syndrome.
    Arvand M; Hahn H
    Zentralbl Bakteriol; 1996 Jul; 284(2-3):164-9. PubMed ID: 8837379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A.
    Stevens DL; Tanner MH; Winship J; Swarts R; Ries KM; Schlievert PM; Kaplan E
    N Engl J Med; 1989 Jul; 321(1):1-7. PubMed ID: 2659990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Major outbreak of toxic shock-like syndrome caused by Streptococcus mitis.
    Lu HZ; Weng XH; Zhu B; Li H; Yin YK; Zhang YX; Haas DW; Tang YW
    J Clin Microbiol; 2003 Jul; 41(7):3051-5. PubMed ID: 12843042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergic activities of streptococcal pyrogenic exotoxin A and lipoteichoic acid in cytokine induction.
    Cusumano V; Fera MT; Carbone M; Anzani Ciliberti F; Bellantoni A; Cusumano V
    New Microbiol; 2000 Jan; 23(1):37-45. PubMed ID: 10946404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Invasive group A streptococcal infections: T1M1 isolates expressing pyrogenic exotoxins A and B in combination with selective lack of toxin-neutralizing antibodies are associated with increased risk of streptococcal toxic shock syndrome.
    Eriksson BK; Andersson J; Holm SE; Norgren M
    J Infect Dis; 1999 Aug; 180(2):410-8. PubMed ID: 10395857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.